China Universal Asset Management Co., Ltd. - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 125 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
China Universal Asset Management Co., Ltd. ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6
+50.0%
2,139
+95.7%
0.00%
+100.0%
Q2 2023$40.0%1,093
-3.2%
0.00%0.0%
Q1 2023$40.0%1,129
+33.5%
0.00%
-50.0%
Q4 2022$4
-99.9%
846
+8.5%
0.00%0.0%
Q3 2022$4,0007800.00%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,637,331$57,405,00037.04%
Bain Capital Life Sciences Investors, LLC 3,700,000$129,722,0008.05%
Cormorant Asset Management, LP 4,928,756$172,802,0007.02%
RA Capital Management 5,427,655$190,294,0002.64%
CM Management, LLC 100,000$3,506,0002.62%
Ghost Tree Capital, LLC 150,000$5,259,0001.54%
ORACLE INVESTMENT MANAGEMENT INC 309,126$10,838,0001.35%
Perceptive Advisors 2,259,224$79,208,0001.15%
Omega Fund Management, LLC 164,577$5,770,0000.65%
Monashee Investment Management LLC 100,000$3,506,0000.65%
View complete list of ATEA PHARMACEUTICALS INC shareholders